PEOPLE - Iris International makes appointment:
This article was originally published in Clinica
Executive Summary
Iris International (Chatsworth, California), a developer of in vitro diagnostic urinalysis systems and digital imaging software, has appointed Peter Donato as corporate vice-president and CFO. Mr Donato has more than 13 years' experience as a financial executive and joins from medical imaging firm Gamma Medica-Ideas. The company will leverage his expertise in cost control, international capital raising and negotiating skills in marketing and distribution deals. Interim CFO Veronica Tarrant resumes her former VP duties in finance and corporate control.
You may also be interested in...
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.